BOT - Anything but charting, page-7132

I didn't find it strange because now it is just a waiting game - the science is approved by the FDA. Up until the CRL, it wasn't.

I'm not sure what you mean by the price getting out of reach if it turns out to be a 2-month approval? Do you mean more out of reach than if it was 6 month approval? I mean, obviously an extra 4 month wait gives people time to hold off jumping in I guess, but I don't quite understand what you're saying. If it is 2-months, then naturally we could expect it to more quickly run up to, perhaps even surpass, the EH recommendation of 31c, but I don't see how any of the dynamics change other than timing.